Definitive Healthcare Stock Price, News & Analysis (NASDAQ:DH) $8.42 +0.17 (+2.06%) (As of 02:39 PM ET) Add Compare Share Share Today's Range$8.07▼$8.4350-Day Range$5.70▼$8.3852-Week Range$5.53▼$14.03Volume197,691 shsAverage Volume782,381 shsMarket Capitalization$979.50 millionP/E RatioN/ADividend YieldN/APrice Target$11.94 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Definitive Healthcare MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside41.8% Upside$11.94 Price TargetShort InterestBearish13.79% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.66Based on 3 Articles This WeekInsider TradingN/AProj. Earnings Growth28.57%From $0.07 to $0.09 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.07 out of 5 starsMedical Sector539th out of 949 stocksPrepackaged Software Industry108th out of 203 stocks 3.3 Analyst's Opinion Consensus RatingDefinitive Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 4 buy ratings, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $11.94, Definitive Healthcare has a forecasted upside of 41.8% from its current price of $8.42.Amount of Analyst CoverageDefinitive Healthcare has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted13.79% of the float of Definitive Healthcare has been sold short.Short Interest Ratio / Days to CoverDefinitive Healthcare has a short interest ratio ("days to cover") of 7.6.Change versus previous monthShort interest in Definitive Healthcare has recently increased by 25.64%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldDefinitive Healthcare does not currently pay a dividend.Dividend GrowthDefinitive Healthcare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DH. Previous Next 2.0 News and Social Media Coverage News SentimentDefinitive Healthcare has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Definitive Healthcare this week, compared to 2 articles on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Definitive Healthcare insiders have not sold or bought any company stock.Percentage Held by Insiders15.27% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Definitive Healthcare are expected to grow by 28.57% in the coming year, from $0.07 to $0.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Definitive Healthcare is -5.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Definitive Healthcare is -5.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDefinitive Healthcare has a PEG Ratio of 5.15. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDefinitive Healthcare has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Definitive Healthcare Stock (NASDAQ:DH)Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing firms and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.Read More DH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DH Stock News HeadlinesNovember 25, 2023 | americanbankingnews.comDefinitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of "Moderate Buy" by BrokeragesNovember 14, 2023 | seekingalpha.comDefinitive Healthcare: Undervalued Vs. Peers Given Revenue Growth And Margin ExpansionDecember 1, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 5, 2023 | benzinga.comDefinitive Healthcare Stock (NASDAQ:DH), Analyst Ratings, Price Targets, PredictionsNovember 3, 2023 | seekingalpha.comDefinitive Healthcare Corp. 2023 Q3 - Results - Earnings Call PresentationNovember 2, 2023 | finance.yahoo.comDefinitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2023November 2, 2023 | finance.yahoo.comDefinitive Healthcare Corp (DH) Reports 14% YoY Revenue Growth in Q3 2023November 1, 2023 | finance.yahoo.comInsiders Re-Evaluate Their US$5.19m Stock Purchase As Definitive Healthcare Falls To US$900mDecember 1, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.October 16, 2023 | finance.yahoo.comDefinitive Healthcare Announces Timing of Its Third Quarter 2023 Financial Results Conference Call and WebcastOctober 5, 2023 | finance.yahoo.comDefinitive Healthcare Names Carrie Lazorchak as Chief Revenue OfficerSeptember 12, 2023 | seekingalpha.comDefinitive Healthcare: Fundamentals Remain Sound But Stock Sentiment Is BadSeptember 8, 2023 | finance.yahoo.comDefinitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 8, 2023 | finance.yahoo.comDefinitive Healthcare Welcomes Scott Stephenson to Board of DirectorsSeptember 5, 2023 | finance.yahoo.comDefinitive Healthcare to Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceAugust 21, 2023 | finance.yahoo.comWhat Makes Definitive Healthcare Corp. (DH) an Attractive Investment?August 18, 2023 | fool.comDefinitive Healthcare (NASDAQ: DH)August 16, 2023 | msn.comGoldman Sachs Maintains Definitive Healthcare Corp - (DH) Neutral RecommendationAugust 15, 2023 | finanznachrichten.deDefinitive Healthcare Corp.: Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2023August 15, 2023 | markets.businessinsider.comGoldman Sachs Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)August 15, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Definitive Healthcare Corp (DH), Clearside Biomedical (CLSD) and Biora Therapeutics (BIOR)August 14, 2023 | axios.comExclusive: Definitive Healthcare to buy analytics startup Populi for $52M cashAugust 14, 2023 | finance.yahoo.comDefinitive Healthcare expands Atlas Technology Install DatasetAugust 14, 2023 | finance.yahoo.comDefinitive Healthcare acquires PopuliAugust 14, 2023 | finance.yahoo.comDefinitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2023August 11, 2023 | benzinga.comDefinitive Healthcare Corp.: Company Investigated by the Portnoy Law FirmAugust 10, 2023 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Definitive Healthcare Corp. - DHSee More Headlines Receive DH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/02/2023Today12/01/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/22/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Prepackaged software Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DH CUSIPN/A CIK1861795 Webwww.definitivehc.com Phone508-720-4224FaxN/AEmployees946Year FoundedN/APrice Target and Rating Average Stock Price Target$11.94 High Stock Price Target$15.00 Low Stock Price Target$9.50 Potential Upside/Downside+41.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($1.62) Trailing P/E RatioN/A Forward P/E Ratio120.14 P/E Growth5.15Net Income$-7,220,000.00 Net Margins-73.75% Pretax Margin-124.82% Return on Equity0.50% Return on Assets0.34% Debt Debt-to-Equity Ratio0.20 Current Ratio2.55 Quick Ratio2.55 Sales & Book Value Annual Sales$222.65 million Price / Sales4.39 Cash Flow$0.73 per share Price / Cash Flow11.57 Book Value$10.35 per share Price / Book0.81Miscellaneous Outstanding Shares116,330,000Free Float98,565,000Market Cap$978.34 million OptionableNot Optionable Beta0.84 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Jason Ronald Krantz (Age 49)Founder & Executive Chairman Comp: $820.92kMr. Robert W. Musslewhite J.D. (Age 53)CEO & Director Comp: $709.08kMr. Jon MaackPresidentMr. Richard Douglas Booth (Age 54)Chief Financial Officer Comp: $562.44kMs. Kate Marie Shamsuddin Jensen (Age 37)Chief Product Officer Comp: $393.26kMr. Scott OberlinkChief Technology OfficerMr. Matt RudermanChief Legal Officer & SecretaryMr. Justin A. SteinmanChief Marketing OfficerMr. Craig HazenfieldChief People OfficerMr. Ram SharmaExecutive Vice President of Life SciencesMore ExecutivesKey CompetitorsCertaraNASDAQ:CERTMannKindNASDAQ:MNKDArdelyxNASDAQ:ARDXCytek BiosciencesNASDAQ:CTKBAkero TherapeuticsNASDAQ:AKROView All CompetitorsInsiders & InstitutionsDeutsche Bank AGBought 3,735 shares on 11/24/2023Ownership: 0.018%Comerica BankBought 391,394 shares on 11/21/2023Ownership: 0.336%Walleye Capital LLCBought 3,242 shares on 11/21/2023Ownership: 0.012%OLD National Bancorp INBought 2,609 shares on 11/17/2023Ownership: 0.018%Ameriprise Financial Inc.Sold 4,970 shares on 11/15/2023Ownership: 0.217%View All Insider TransactionsView All Institutional Transactions DH Stock Analysis - Frequently Asked Questions Should I buy or sell Definitive Healthcare stock right now? 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DH shares. View DH analyst ratings or view top-rated stocks. What is Definitive Healthcare's stock price target for 2024? 8 brokers have issued 12-month target prices for Definitive Healthcare's stock. Their DH share price targets range from $9.50 to $15.00. On average, they anticipate the company's share price to reach $11.94 in the next twelve months. This suggests a possible upside of 41.8% from the stock's current price. View analysts price targets for DH or view top-rated stocks among Wall Street analysts. How have DH shares performed in 2023? Definitive Healthcare's stock was trading at $10.99 at the beginning of 2023. Since then, DH stock has decreased by 23.4% and is now trading at $8.42. View the best growth stocks for 2023 here. Are investors shorting Definitive Healthcare? Definitive Healthcare saw a increase in short interest in November. As of November 15th, there was short interest totaling 6,370,000 shares, an increase of 25.6% from the October 31st total of 5,070,000 shares. Based on an average daily trading volume, of 840,700 shares, the days-to-cover ratio is currently 7.6 days. Currently, 13.8% of the shares of the stock are short sold. View Definitive Healthcare's Short Interest. When is Definitive Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024. View our DH earnings forecast. How were Definitive Healthcare's earnings last quarter? Definitive Healthcare Corp. (NASDAQ:DH) issued its earnings results on Thursday, November, 2nd. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.02 by $0.01. The company had revenue of $65.33 million for the quarter, compared to the consensus estimate of $63.60 million. Definitive Healthcare had a negative net margin of 73.75% and a positive trailing twelve-month return on equity of 0.50%. What ETFs hold Definitive Healthcare's stock? ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Alger Weatherbie Enduring Growth ETF (AWEG), Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). What guidance has Definitive Healthcare issued on next quarter's earnings? Definitive Healthcare updated its fourth quarter earnings guidance on Thursday, November, 2nd. The company provided EPS guidance of $0.06-0.08 for the period, compared to the consensus estimate of $0.03. The company issued revenue guidance of $65.5-66.5 million, compared to the consensus revenue estimate of $66.90 million. When did Definitive Healthcare IPO? (DH) raised $350 million in an initial public offering (IPO) on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share. Who are Definitive Healthcare's major shareholders? Definitive Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional investors include JPMorgan Chase & Co. (4.36%), Conestoga Capital Advisors LLC (4.35%), Brown Advisory Inc. (3.50%), Riverbridge Partners LLC (2.30%), Fred Alger Management LLC (2.20%) and Clearbridge Investments LLC (1.94%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc. View institutional ownership trends. How do I buy shares of Definitive Healthcare? Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:DH) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Definitive Healthcare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.